{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-034207","form_type":"8-K","ticker":"PTCT","cik":"0001070081","company_name":"PTC THERAPEUTICS, INC.","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.497180+00:00","generated_at":"2026-05-15T08:57:55.883219+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"PTC Therapeutics appoints biotech banking veteran Jessica Chutter to board","bullets":["Jessica Chutter appointed to board effective March 24, 2026, as Class I director.","Chutter spent 40+ years at Morgan Stanley, most recently as Managing Director and Chair of Biotech Investment Banking.","She was involved in ~$80B in capital raising and ~$85B in strategic transactions at Morgan Stanley.","Initial director equity grant: 3,475 stock options (36-month monthly vest) and 4,000 RSUs (3-year annual vest).","Also receives pro-rated annual grant: 2,896 stock options and 3,333 RSUs; eligible for future grants per board policy."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-034207","json":"https://secwatch.observer/filing/0001104659-26-034207.json","markdown":"https://secwatch.observer/filing/0001104659-26-034207.md","text":"https://secwatch.observer/filing/0001104659-26-034207.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070081/000110465926034207/0001104659-26-034207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070081/000110465926034207/tmb-20260324x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:57:55.883219+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}